D&P Bioinnovations

Tulane University, $5,000

A large number of esophagectomies (surgery to fix a damaged esophagus) are performed each year as the only option to treat esophageal cancer. But quality of life after surgery can be very poor: the excised tissue is often reconstructed from the stomach or large intestine, which means patients have to rely on feeding tubes to stay alive. This team is investigating a new therapy in which stem cells are used to regenerate normal esophageal tissue, avoiding reconstruction and feeding tubes altogether.

By continuing to use the site, you agree to the use of cookies. Read More

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.